2024-07-16 11:23 |
[DZNE-2024-00857]
Journal Article
Riemer, M. ; Wolbers, T. ; van Rijn, H.
Memory traces of duration and location in the right intraparietal sulcus
Time and space form an integral part of every human experience, and for the neuronal representation of these perceptual dimensions, previous studies point to the involvement of the right-hemispheric intraparietal sulcus and structures in the medial temporal lobe. Here we used multi-voxel pattern analysis (MVPA) to investigate long-term memory traces for temporal and spatial stimulus features in those areas. [...]
OpenAccess: PDF PDF (PDFA);
Detailed record - Similar records
|
2024-07-16 11:22 |
Detailed record - Similar records
|
2024-07-16 11:21 |
Detailed record - Similar records
|
2024-07-16 11:20 |
Detailed record - Similar records
|
2024-07-16 11:06 |
[DZNE-2024-00852]
Journal Article (Review Article)
Geenen, R. W. F. ; Roditi, G. ; Bellin, M.-F. ; et al
Safe use of contrast media in myasthenia gravis: systematic review and updated European Society of Urogenital Radiology Contrast Media Safety Committee guidelines.
It is uncertain whether modern iodine-based or gadolinium-based contrast media (CM) administration can lead to increased symptoms in patients with myasthenia gravis.A systematic search in Medline was conducted for studies describing the symptomatology of myasthenia gravis patients before and after receiving intravenous (IV) CM and having a matched control group of myasthenia gravis patients who did not receive IV CM.Three retrospective studies were selected with a total of 374 myasthenia gravis patients who received iodine-based CM and a total of 313 myasthenia gravis patients who underwent unenhanced CT and served as controls. Pooling of the data from the three retrospective studies showed that in 23 of 374 patients, increased symptoms after iodine-based CM administration were described (6.1%). [...]
OpenAccess: PDF PDF (PDFA);
Detailed record - Similar records
|
2024-07-16 11:05 |
Detailed record - Similar records
|
2024-07-16 11:04 |
[DZNE-2024-00850]
Journal Article
Wiesner, D. ; Feldengut, S. ; Woelfle, S. ; et al
Neuropeptide FF (NPFF)-positive nerve cells of the human cerebral cortex and white matter in controls, selected neurodegenerative diseases, and schizophrenia.
We quantified and determined for the first time the distribution pattern of the neuropeptide NPFF in the human cerebral cortex and subjacent white matter. To do so, we studied n = 9 cases without neurological disorders and n = 22 cases with neurodegenerative diseases, including sporadic amyotrophic lateral sclerosis (ALS, n = 8), Alzheimer's disease (AD, n = 8), Pick's disease (PiD, n = 3), and schizophrenia (n = 3). [...]
Detailed record - Similar records
|
2024-07-16 11:01 |
Detailed record - Similar records
|
2024-07-16 10:53 |
Detailed record - Similar records
|
2024-07-16 10:52 |
Detailed record - Similar records
|
|
|